Georgia Pharmacy CE Requirement 30-Hour Package
Included Courses
Courses included in this package. Click on a course to learn more.
- Climate Change and Parasitic Infections 2
Course release date: 7/10/2023
About the Course
The purpose of this course is to review current knowledge about the management of parasitic infections and provide healthcare workers with information on the changing landscape of such infections as climate changes.
- Educating Patients: Creating Teaching Moments in Practice 4Course release date: 12/21/2022
About the Course
Effective education is essential to help patients and family gain knowledge. All healthcare professionals (HCPs) can identify teaching opportunities to assess and provide effective education. The purpose of this course is to provide HCPs with current evidence-based information to help them learn and apply skills and practice for effective patient and family teaching in a variety of settings. - Heart Failure: Evidence Review and Management 2Release Date: 8/10/2022
About the Course
Heart failure is a complex clinical syndrome associated with increasing morbidity, mortality, and economic burden. Despite evidence supporting guideline-directed therapy and management for reduction of morbidity and mortality, these medications are still underprescribed. According to the CHAMP-HF registry, among eligible patients, only 22% were prescribed essential heart failure medications per guideline recommendations ((Greene et al., 2018). Healthcare providers have an essential role in improving outcomes with heart failure by bridging the gap between guideline-directed recommendations and actual clinical practice. The learning outcomes of this activity will help clinicians understand this healthcare gap by reviewing the current evidence-based pharmacotherapy recommendations for HF treatment through analyzing clinical trials and guidelines.
- Pain Management: Evidence-Based Guidance for Prescribing Opioids 5
Course release date: 6/12/2023
About the Course
This course will provide a general review of federal and state-controlled substance regulations and the prescribing practices for controlled substances, including drug diversion. However, the focus is on clinical safety considerations when prescribing non-cancer-related opioid medications for acute/chronic pain in adults.
- Pharmacotherapy to Assist with Smoking Cessation 3Release Date: 1/26/2021
About the Course:
After completing this course, pharmacists will be able to help select first-line pharmacotherapy to assist smokers in quitting, educate smokers on potential adverse effects of these pharmacotherapies, and provide counseling that includes how and when to properly take the medication - The Complications of Chronic Kidney Disease, Second Edition 2
Release Date: 7/10/2023
About the Course:
This course serves as a review of chronic kidney disease (CKD) and the medications used to prevent adverse effects of CKD and slow disease progression. - The Essentials of Infection Prevention 4
Course release date: 7/10/2023
About the Course
The COVID-19 pandemic made all healthcare workers acutely aware of infection prevention and control measures. The pandemic has highlighted the need for ongoing education to maintain a knowledge and skill level appropriate for implementing strategies to prevent healthcare-associated infections and to prepare for the next pandemic. Understanding where reservoirs are harboring pathogens and strategies to prevent transmission in healthcare settings is critical. This course will examine best practices for infection prevention, such as hand hygiene, personal protective equipment, transmission-based precautions, cleaning and disinfection, and injection safety
- The Pharmacist's Role in the Opioid Crisis, 2nd Edition 6
Course Release: 1/9/2024
About the course
This course will provide pharmacists practicing in healthcare systems and community pharmacy settings an overview of contemporary considerations for ways that the opioid crisis intersects with pharmacy practice. This course will provide pharmacists with a history of the current state of the opioid crisis and how pharmacy practice has expanded to meet patient and community needs as well as ethical dimensions of the opioid crisis and the role of social determinants of health in opioid-related disparities. This course will provide pharmacists with an understanding of the disease state of opioid use disorder and how opioids affect the brain, how the pharmacist can be supportive of patients with opioid use disorder to reduce stigma and facilitate treatment-seeking, and the benefits of medications for opioid use disorder; participants will review the 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain (2022 Clinical Practice Guideline).
- The Pharmacologic Management of Anxiety in Adults 2Release Date: 7/10/2023About the CourseAnxiety disorders are the most commonly diagnosed psychiatric disorders, with an estimated 264 million persons globally suffering from an anxiety disorder. It’s estimated that 19.1% of adults in the United States (U.S.) are affected by at least one anxiety disorder; this number increases to 31.9% in U.S. adolescents. Common anxiety disorders include generalized anxiety disorder (GAD), panic disorder (PD), specific phobias, agoraphobia, social anxiety disorder (SAD), and separation anxiety disorder. This course reviews the diagnosis and pharmacological management of anxiety disorders, as well as medications which can cause or exacerbate anxiety symptoms.